Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-10

Clinical Trial Update: Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating azithromycin-based therapy to induce remission in active pediatric Crohn's disease; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)

Snippet

Sponsor: Prof. Arie Levine | Conditions: Crohn's Disease | Phase 4 | Status: COMPLETED